All entries for: Atara Biotherapeutics

November 12, 2025

Atara Biotherapeutics

Neutral Outlook

Thousand Oaks, CA
201-500 employees

Since the May 12, 2025 “most favored nation” executive order, the Trump administration has continued to exert pressure on drug manufacturers toimplement “most favored nation” pricing and has suggested that it may impose significant tariffs on pharmaceuticals if such pricing is not implemented.

May 14, 2025

Atara Biotherapeutics

Layoffs

Thousand Oaks, CA
201-500 employees

Atara Biotherapeutics continues to shed its staff, announcing on Monday that it will downsize by approximately 30%, leaving only 23 employees behind who are “essential to executing on the Company’s strategic priorities,” according to an SEC filing.

Disease Area: Hematology, Immune Diseases, Multiple, Oncology
Drug Type: Biologic
Scroll to Top